Relypsa Inc
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2012 | $65 M | No. 2 | $50 to $250 million | equity, options | SEC | |
| Sep 2010 | $70 M | No. 1 | $50 to $250 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Relypsa Inc chose not to state its revenue in its newest notice of a funding round (Dec 2012).
SEC Form D · Dec 2012
The industry group it chose in its notices: Biotechnology.
SEC Form D · Dec 2012
That is all the official record says: Relypsa Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
11 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| 5AM Co-Investors III, L.P. | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| 5am Co-Investors II LP | Fund or asset manager | not stated | not stated | Held Series A-1, B-1, B-2, C-1 and C-2 preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| 5AM Partners III, LLC | Fund or asset manager | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| 5AM Partners II, LLC | Fund or asset manager | not stated | not stated | Held Series A-1, B-1, B-2, C-1 and C-2 preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| 5am Ventures III, L.P. | Venture capital | not stated | not stated | Held Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| 5AM Ventures II LP | Venture capital | not stated | not stated | Held Series A-1, B-1, B-2, C-1 and C-2 preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| New Leaf Venture Management I, L.L.C. | Venture capital | not stated | not stated | Held Series A-1, B-1, B-2, C-1 and C-2 preferred (Form 3, 2013) | SEC Form 3 |
| New Leaf Venture Management I, L.P. | Venture capital | not stated | not stated | Held Series A-1, B-1, B-2, C-1 and C-2 preferred (Form 3, 2013) | SEC Form 3 |
| New Leaf Ventures I, L.P. | Venture capital | not stated | not stated | Held Series A-1, B-1, B-2, C-1 and C-2 preferred (Form 3, 2013) | SEC Form 3 |
| Orbimed Advisors LLC | Fund or asset manager | not stated | not stated | Held Series B-1, B-2, C-1 and C-2 preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| OrbiMed Capital GP IV LLC | Fund or asset manager | not stated | not stated | Held Series B-1, B-2, C-1 and C-2 preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 15 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Claire M. Lockey | Executive officer | Dec 2012 |
| Gerrit Klaerner | Executive officer | Dec 2012 |
| Jerry M. Buysse | Executive officer | Dec 2012 |
| Lance M. Berman | Executive officer | Dec 2012 |
| Ronald Krasnow | Executive officer | Dec 2012 |
| Wilhelm M. Stahl | Executive officer | Dec 2012 |
| Jim M. Johnson | Executive officer | Aug 2012 |
| Gerrit Klaerner | Director | Dec 2012 |
| Jonathan M. Silverstein | Director | Dec 2012 |
| Klaus M. Veitinger | Director | Dec 2012 |
| Paul M. Hastings | Director | Dec 2012 |
| Ron M. Hunt | Director | Dec 2012 |
| Scott M. Rocklage | Director | Dec 2012 |
| Thomas M. Schuetz | Director | Dec 2012 |
| Deepa M. Pakianathan | Director | Oct 2012 |
| Vijay M. Lathi | Director | Aug 2011 |
| Janis M. Naeve | Director | Sep 2010 |